Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis
Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis
Tranzyme Pharma announced positive top-line results today from a Phase 2, double-blind, placebo-controlled study evaluating TZP-102 capsules in diabetic patients with gastroparesis, a serious disorder characterized by the inability of the stomach to empty food efficiently. The study achieved a clinically meaningful and statistically significant improvement in critical gastroparesis-related …
Read more on News-Medical-Net
Related posts:
- 55 Per Cent Of New Dialysis Patients Diabetic - Doctor
- Clinical trial for diabetic macular edema enrolling patients
- Does anyone know where I can find a diabetic diet plan like the doctor gives patients?
- Electronic Medical Records Help Improve Diabetic Health Care
- Healthy Dark Chocolate and Your Diabetic Health — Part 1